Cargando…

Contributions of Circulating microRNAs for Early Detection of Lung Cancer

SIMPLE SUMMARY: Blood-based cancer biomarkers are a minimally invasive means to achieve improved assessment of risk and/or earlier detection of lung cancer. Using serum samples from individuals that went on to develop lung cancer within one year following blood draw and from matched controls, we inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vykoukal, Jody, Fahrmann, Johannes F., Patel, Nikul, Shimizu, Masayoshi, Ostrin, Edwin J., Dennison, Jennifer B., Ivan, Cristina, Goodman, Gary E., Thornquist, Mark D., Barnett, Matt J., Feng, Ziding, Calin, George A., Hanash, Samir M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454665/ https://www.ncbi.nlm.nih.gov/pubmed/36077759 http://dx.doi.org/10.3390/cancers14174221

Ejemplares similares

Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer
por: Fahrmann, Johannes F., et al.
Publicado: (2020)

The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer
por: León-Letelier, Ricardo A., et al.
Publicado: (2023)

Extracellular Vesicles Mediate B Cell Immune Response and Are a Potential Target for Cancer Therapy
por: Kato, Taketo, et al.
Publicado: (2020)

Extracellular Vesicles in Lung Cancer: Prospects for Diagnostic and Therapeutic Applications
por: Kato, Taketo, et al.
Publicado: (2021)

Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis
por: León-Letelier, Ricardo A., et al.
Publicado: (2023)

Plasma-Derived Extracellular Vesicles Convey Protein Signatures That Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas
por: Fahrmann, Johannes F., et al.
Publicado: (2020)

c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy
por: Chen, Yihui, et al.
Publicado: (2023)

Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma
por: Vykoukal, Jody, et al.
Publicado: (2017)

A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response
por: Irajizad, Ehsan, et al.
Publicado: (2022)

A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer
por: Fahrmann, Johannes F, et al.
Publicado: (2018)

Plasma Based Protein Signatures Associated with Small Cell Lung Cancer
por: Fahrmann, Johannes F., et al.
Publicado: (2021)

Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma
por: Fahrmann, Johannes F., et al.
Publicado: (2022)

Protein citrullination as a source of cancer neoantigens
por: Katayama, Hiroyuki, et al.
Publicado: (2021)

A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer
por: Fahrmann, Johannes F., et al.
Publicado: (2021)

Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia
por: Park, Soyoung, et al.
Publicado: (2022)

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer
por: Vykoukal, Jody, et al.
Publicado: (2020)

Circulating microRNAs and prediction of asthma exacerbation in childhood asthma
por: Kho, Alvin T., et al.
Publicado: (2018)

Circulating MicroRNAs: Association with Lung Function in Asthma
por: Kho, Alvin T., et al.
Publicado: (2016)

Circulating microRNAs in aging
por: Bonafè, Massimiliano, et al.
Publicado: (2015)

Circulating microRNAs in Medicine
por: Pozniak, Tetiana, et al.
Publicado: (2022)

MicroRNAs circulate around Alzheimer's disease
por: Smith-Vikos, Thalyana, et al.
Publicado: (2013)

CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop
por: Chen, Yihui, et al.
Publicado: (2021)

Circulating MicroRNAs Are Not Eliminated by Hemodialysis
por: Martino, Filippo, et al.
Publicado: (2012)

Circulating MicroRNAs as Biomarkers for Sepsis
por: Benz, Fabian, et al.
Publicado: (2016)

Circulating microRNAs in Fabry Disease
por: Xiao, Ke, et al.
Publicado: (2019)

Circulating MicroRNAs in Gastrointestinal Cancer
por: Ohtsuka, Masahisa, et al.
Publicado: (2021)

Stability of circulating microRNAs in serum
por: Kupec, Tomas, et al.
Publicado: (2022)

Circulating microRNAs in Hidradenitis Suppurativa
por: De Felice, Bruna, et al.
Publicado: (2022)

AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality
por: Grieshober, Laurie, et al.
Publicado: (2020)

Circulating microRNAs in patients with intracranial aneurysms
por: Meeuwsen, John A. L., et al.
Publicado: (2017)

Reproducibility of Circulating MicroRNAs in Stored Plasma Samples
por: Bertoia, Monica L., et al.
Publicado: (2015)

Circulating microRNAs: promising breast cancer Biomarkers
por: Heneghan, Helen M, et al.
Publicado: (2011)

Circulating MicroRNAs: Potential Biomarkers for Cancer
por: Yu, De-Cai, et al.
Publicado: (2011)

Circulating microRNAs as biomarkers - True Blood?
por: Schöler, Nathalie, et al.
Publicado: (2011)

Circulating MicroRNAs as Biomarkers of Acute Stroke
por: Sepramaniam, Sugunavathi, et al.
Publicado: (2014)

Intestinal and Circulating MicroRNAs in Coeliac Disease
por: Felli, Cristina, et al.
Publicado: (2017)

Circulating MicroRNAs in Cancer: Potential and Challenge
por: Cui, Mengying, et al.
Publicado: (2019)

Circulating microRNAs and Their Role in Multiple Myeloma
por: Federico, Cinzia, et al.
Publicado: (2019)

Role of circulating microRNAs in liver diseases
por: Loosen, Sven H, et al.
Publicado: (2017)

Role of sepsis modulated circulating microRNAs
por: Szilágyi, Bernadett, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ru1gqdl48p36ojmiijeaef2ql